| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,340 | 1,490 | 10:34 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:00 | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2026 | 70 | GlobeNewswire (Europe) | Accelerating performance validates our partnership model
Third quarter 2026 (July - September)Total revenue amounted to SEK 58.4 (48.4) million, an increase of SEK 10.0 million corresponding to 20.6%.Net... ► Artikel lesen | |
| BACTIGUARD Aktie jetzt für 0€ handeln | |||||
| 14.07. | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | 387 | GlobeNewswire (Europe) | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| 19.05. | Bactiguard Holding AB: Bulletin from Bactiguard Holding AB's (publ) Annual General Meeting | 282 | GlobeNewswire (Europe) | At Bactiguard Holding AB's (publ) Annual General Meeting (AGM) on 19 May 2026, the following resolutions were made:
The AGM adopted the income statements and balance sheets for 2025 and decided that... ► Artikel lesen | |
| 11.05. | Bactiguard Holding AB: Bactiguard and BD strengthen global partnership expanding access to Foley catheters designed to reduce infection risk for patients worldwide | 477 | GlobeNewswire (Europe) | Bactiguard Holding AB (publ) today announces an update to its long standing collaboration with license partner BD (Becton, Dickinson & Company), a leading global medical technology company, through... ► Artikel lesen | |
| 23.04. | Bactiguard Holding AB: Bactiguard Holding AB's interim report first quarter 2026 | 348 | GlobeNewswire (Europe) | Building momentum through partnerships, regulatory progress and organizational strength
First quarter 2026 (January - March)Total revenue amounted to SEK 46.9 (62.7) million, a decrease of SEK 15.8... ► Artikel lesen | |
| 05.02. | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | 524 | GlobeNewswire (Europe) | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen | |
| 19.12.25 | Bactiguard Holding AB: Bactiguard announces updated trauma license agreement with Zimmer Biomet | 499 | GlobeNewswire (Europe) | Bactiguard continues the collaboration with Zimmer Biomet in an updated agreement, giving Zimmer Biomet non-exclusive rights to continue to commercialize the ZNN Bactiguard coated trauma nail system... ► Artikel lesen | |
| 23.10.25 | Bactiguard Holding AB: Bactiguard Holding AB's interim report third quarter 2025 | 471 | GlobeNewswire (Europe) | Continued profitability and clinical evidence supporting future growth
Third quarter 2025 (July - September)
Total revenue amounted to SEK 48.4 (73.9) million, a decrease of SEK 25.5 million corresponding... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,438 | -2,96 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,072 | -2,69 % | PAUKENSCHLAG: Könnte die Aktie von Sernova Biotherapeutics nach 12,7 % Plus jetzt komplett durchstarten? - Das dürfen Sie nicht verpassen! | ||
| BOSTON SCIENTIFIC | 39,270 | -0,88 % | TD Cowen reiterates Boston Scientific stock rating on 2027 outlook | ||
| SYNLAB | - | - | EQS-News: SYNLAB: Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics | EQS-News: SYNLAB
/ Key word(s): Miscellaneous
Synnovis and Apian partner to advance drone and autonomous robotics in healthcare logistics
07.09.2026 / 09:31 CET/CEST
The... ► Artikel lesen | |
| PAUL HARTMANN | 189,00 | +0,27 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 10,850 | -1,09 % | Dividendenbekanntmachungen (29.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 77 BANK LTD JP3352000008 52 JPY 0,2906 EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1799 EUR ACOM CO LTD JP3108600002 11 JPY 0... ► Artikel lesen | |
| EMBECTA | 5,836 | -1,78 % | Dividendenbekanntmachungen (27.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADDTECH AB SE0014781795 3,6 SEK 0,3243 EUR ALLIANCE WITAN PLC GB00B11V7W98 0,0733 GBP 0,0855 EUR ATMUS FILTRATION TECHNOLOGIES... ► Artikel lesen | |
| ADDLIFE | 16,680 | 0,00 % | AddLife Q3 2026 slides: profit surges 61% on margin gains, M&A ramps up | ||
| ENOVIS | 18,300 | -1,61 % | Enovis Corporation: Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics | Enhances Enovis' enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room, Creates a robotics... ► Artikel lesen | |
| COVETRUS | - | - | Laufende Fusionskontrollverfahren: Cencora Inc., Conshohocken, PA/USA (früher AmerisourceBergen); Erwerb eines Minderheitsanteils an Covetrus, Portland, ME/USA (weitere Aktionäre: Fonds von CD&R, Clayton, Dubilier, Rice, NY/USA, sowie von TPG Inc, Fort Wo | Datum der Anmeldung:04.05.2026Aktenzeichen:B3-61/26Unternehmen:Cencora Inc., Conshohocken, PA/USA (früher AmerisourceBergen); Erwerb eines Minderheitsanteils an Covetrus, Portland, ME/USA (weitere Aktionäre:... ► Artikel lesen | |
| PULMONX | 1,540 | -3,75 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,82 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| AVEANNA HEALTHCARE | 12,990 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,330 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report |